Revance to Release Fourth Quarter and Full Year 2020 Financial Results on Monday, February 22, 2021
Conference Call Scheduled for Monday, February 22, 2021 at 4:30 p.m. ET. NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a…
Pharmaceuticals, Biotechnology and Life Sciences
Conference Call Scheduled for Monday, February 22, 2021 at 4:30 p.m. ET. NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a…
Flavors & Extracts Group Reports Double Digit Revenue and Profit Growth Food and Pharmaceutical Colors Reports Mid-Single Digit Revenue Growth…
Flavors & Extracts Group Reports Double Digit Revenue and Profit Growth Food and Pharmaceutical Colors Reports Mid-Single Digit Revenue Growth…
Flavors & Extracts Group Reports Double Digit Revenue and Profit Growth Food and Pharmaceutical Colors Reports Mid-Single Digit Revenue Growth…
Flavors & Extracts Group Reports Double Digit Revenue and Profit Growth Food and Pharmaceutical Colors Reports Mid-Single Digit Revenue Growth…
Flavors & Extracts Group Reports Double Digit Revenue and Profit Growth Food and Pharmaceutical Colors Reports Mid-Single Digit Revenue Growth…
Flavors & Extracts Group Reports Double Digit Revenue and Profit Growth Food and Pharmaceutical Colors Reports Mid-Single Digit Revenue Growth…
– Approved for Adult Patients with HER2-Positive Metastatic Breast Cancer Who Have Received at Least Two Prior Anti-HER2 Treatment Regimens…
BOULDER, Colo.–(BUSINESS WIRE)–Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced…
More Than Twice As Many Transplant Recipients With Refractory, With or Without Resistance (R/R), Cytomegalovirus (CMV) Infection/Disease Treated With Maribavir,…